Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1990-03-05
1993-10-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514 2, 514 19, A61K 3324, A61K 3100
Patent
active
052523420
ABSTRACT:
The present invention comprises a method of sensitizing cancer cells to cisplatin or other cytotoxic agents and augmenting the sensitivity of cancer cells to these cytotoxic agents. The invention provides a method to treat cancer and other cell proliferative diseases by the administration of a sensitizing agent prior to or concurrently with the administration of a cytotoxic agent.
REFERENCES:
patent: 4571336 (1986-02-01), Houck et al.
patent: 4863902 (1989-09-01), Harunbu et al.
patent: 4925922 (1980-05-01), Byers et al.
patent: 4959353 (1990-09-01), Brown et al.
patent: 4962091 (1990-10-01), Eppstein et al.
C.A. vol. 106 (21)-169447(u).
C.A. vol. 109 (25)-222460(h).
C.A. vol. 110 (9)-69068(k).
C.A. vol. 113 (21)-185362(n).
Andrews Paul A.
Christen Randolph D.
Howell Stephen B.
Isonishi Seiji
Criares T. J.
Dreger Walter H.
Goldberg Jerome D.
The Regents of the University of California
LandOfFree
Enhancement of anti-neoplastic drug efficacy using EGF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of anti-neoplastic drug efficacy using EGF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of anti-neoplastic drug efficacy using EGF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1902860